These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15123072)

  • 1. Microbial-gut interactions in health and disease. Irritable bowel syndrome.
    Verdu EF; Collins SM
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):315-21. PubMed ID: 15123072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between commensal bacteria and gut sensorimotor function in health and disease.
    Barbara G; Stanghellini V; Brandi G; Cremon C; Di Nardo G; De Giorgio R; Corinaldesi R
    Am J Gastroenterol; 2005 Nov; 100(11):2560-8. PubMed ID: 16279914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in intestinal microbial flora and human disease.
    Othman M; Agüero R; Lin HC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):11-6. PubMed ID: 18043226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM; Flourie B
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome.
    Collins S; Verdu E; Denou E; Bercik P
    Dig Dis; 2009; 27 Suppl 1():85-9. PubMed ID: 20203502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and microflora.
    Pimentel M; Chang C
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics and functional gastrointestinal disorders in children.
    Vandenplas Y; Benninga M
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the intestinal microbiota and functional bowel symptoms.
    Ringel Y; Carroll IM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):141-50, vii. PubMed ID: 19232285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
    Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R; Savarese MF; Gargano R
    Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota are transiently altered during Salmonella-induced gastroenteritis.
    Gibson DL; Vallance BA
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):525-9. PubMed ID: 19072400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and the role of probiotics in therapy.
    Quigley EM
    Curr Opin Pharmacol; 2011 Dec; 11(6):593-603. PubMed ID: 21996283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.